The effect of oral L-arginine supplementation on improvement of cardiovascular function and pulmonary artery pressure in patients with major and Intermedia beta-thalassemia
Phase 3
Recruiting
- Conditions
- Betha thalasemia.Beta thalassemiaD56.1
- Registration Number
- IRCT20210220050430N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Beta thalassemia major
Above 15 years
Thalassemia intermedia
Exclusion Criteria
Pregnancy
Diadetes
Sever kidney disease
Sever liver disease
Sever cardiac disease
History of taking this supplement
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary hypertension. Timepoint: 2 month. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method